CN Patent

CN110072523A — 通过脑神经的药理皮肤激活来治疗与神经退行性病症相关的症状

Assigned to Glia LLC · Expires 2019-07-30 · 7y expired

What this patent protects

一种用于治疗神经退行性病况的症状的方法。该方法包括将含有性类固醇或大麻素或两者的混合物的组合物局部地施用至前额，或施用至受试者的外耳的区域(不包括耳道)，或施用至这些解剖位置两者。通过该方法可治疗的症状是运动症状或非运动症状。

USPTO Abstract

一种用于治疗神经退行性病况的症状的方法。该方法包括将含有性类固醇或大麻素或两者的混合物的组合物局部地施用至前额，或施用至受试者的外耳的区域(不包括耳道)，或施用至这些解剖位置两者。通过该方法可治疗的症状是运动症状或非运动症状。

Drugs covered by this patent

Patent Metadata

Patent number
CN110072523A
Jurisdiction
CN
Classification
—
Expires
2019-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Glia LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.